Financial insights of CLYM

MyFinsight

For the year ending 2025-12-31.

Income Statement	2025-12-31
Research and development expense	46,713
Acquired in-process research and development, related party	0
General and administrative	21,170
Total operating expenses	67,883
Total loss from operations	-67,883
Interest income	8,323
Foreign currency loss	-291
Total other income (expense)	8,032
Net loss	-59,851
Unrealized gain on marketable securities	412
Comprehensive loss	-59,439

Basic EPS	-0.88
Diluted EPS	-0.88
Basic Average Shares	67,812,145
Diluted Average Shares	67,812,145

Unit: Thousand (K) dollars (except for numbers of shares and EPS).